Correction: Analysis of Immune-Inflammatory Gene Networks and Drug Forecasting in Polycystic Ovary Syndrome and Type 2 Diabetes Mellitus: A Study Utilizing Bioinformatics and Experimental Validation - Summary - MDSpire

Correction: Analysis of Immune-Inflammatory Gene Networks and Drug Forecasting in Polycystic Ovary Syndrome and Type 2 Diabetes Mellitus: A Study Utilizing Bioinformatics and Experimental Validation

  • By

  • Xuemeng Liu

  • Yanlei Wang

  • Qiuhan Bi

  • Ying Zhang

  • Shumin Wang

  • Pan Yang

  • Jie Pei

  • Weixi Zhu

  • Yijing Chen

  • Zhiguo Zhang

  • Beili Chen

  • Qiu Zhang

  • Yi Zhang

  • Tian Jiang

  • April 24, 2026

  • 0 min

Share

Objective:

To correct the authorship of the original study regarding immune-inflammatory gene networks and drug prediction in polycystic ovary syndrome and type 2 diabetes mellitus.

Approach:
    Key Findings:
    • Xuemeng Liu was omitted as an equal contributing author.
    • The dagger symbol indicating equal contribution was missing next to Liu's name.
    Interpretation:

    The correction ensures proper attribution of contributions among authors in the study.

    Conclusion:

    The original article has been updated to reflect the correct authorship.

    Sources:

Original Source(s)

Correction: Analysis of Immune-Inflammatory Gene Networks and Drug Forecasting in Polycystic Ovary Syndrome and Type 2 Diabetes Mellitus: A Study Utilizing Bioinformatics and Experimental Validation

  • by Xuemeng Liu, Yanlei Wang, Qiuhan Bi, Ying Zhang, Shumin Wang, Pan Yang, Jie Pei, Weixi Zhu, Yijing Chen, Zhiguo Zhang, Beili Chen, Qiu Zhang, Yi Zhang, Tian Jiang

  • April 24, 2026

Related Content

Steroid Strategies in Diabetic Macular Edema

Editorial: Polycystic ovarian syndrome in adolescence

Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance